Growth hormone targeting polypeptides
AssigneeThe University of Chicago
InventorsAnthony A. KOSSIAKOFF, Tomasz SLEZAK
Life of this patent
Estimating the term…
Abstract
Aspects of the present disclosure are directed to growth hormone (GH)-targeting polypeptides, including antibodies, anti-body-drug conjugates, antibody fragments, antibody-like molecules, and chimeric receptors. Also disclosed herein are nucleic acids encoding for such GH-targeting polypeptides and cells comprising such nucleic acids. Described are methods for treatment of acromegaly using GH-targeting polypeptides.
Claims59
An antibody or antigen binding fragment comprising a heavy chain variable region and a light chain variable region, wherein the heavy chain variable region comprises a HCDR1, HCDR2, and HCDR3 having at least 80% sequence identity to the HCDR1, HCR2, HCR3 from a heavy chain variable region of a antibody clone of Table 1 and wherein the light chain variable region comprises a LCDR1, LCDR2, and LCDR3 having at least 80% sequence identity to the LCDR1, LCDR2, and LCDR3 from the light chain variable region of the same antibody clone of Table 1.
Dependencies are inferred from the claim text.